//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
To accelerate #malaria elimination, next-gen antimalarials must be developed with simplicity in mind. LAIs could provide lasting protection from a single intervention. MMV & partners recently explored how this innovation can support high-burden settings: bit.ly/4wSkvCB
15h
bit.ly
MMV hosts workshop to advance long‑acting injectables for high‑burden diseases | Medicines for Malaria Venture
Medicines for Malaria Venture (MMV)